
    
      This study is a prospective, multi-center study to evaluate the clinical and radiographic
      outcomes of ViBone in patients undergoing ACDF or lumbar interbody fusion. Data will be
      gathered for up to 50 subjects undergoing ACDF surgery and up to 50 subjects undergoing
      lumbar fusion surgery using ViBone. Total enrollment is expected to be approximately 100
      subjects. The purpose of this study is to assess clinical and radiographic outcomes in
      patients who undergo 1-3 level ACDF or lumbar interbody fusion surgery using ViBone. Subjects
      will be followed for 12 months following surgery.
    
  